With three FDA-approved treatments now available, clinicians must learn to spot the early signs and understand the evolving science behind hidradenitis suppurativa (HS), a painful and stigmatizing disease....
In their secondary analysis of the Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma randomized clinical trial, researchers evaluated the 5-year efficacy of...
A phase 3 trial evaluating apremilast in children and adolescents with moderate-to-severe plaque psoriasis showed improvements in disease severity compared with placebo over 16 weeks.
A ceramide and niacinamide-containing moisturizer (CCM) significantly enhances acne treatment outcomes by reducing lesions and improving skin barrier function when used alongside standard anti-acne...
A recent phase 3b long-term extension study assessed the safety and efficacy of deucravacitinib over 2 years in patients with moderate-to-severe plaque psoriasis.
Researchers evaluated the association between two surgical excision approaches and overall survival for patients with pathologically confirmed, localized, early-stage Merkel cell carcinoma.
Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...
In a retrospective cohort study, researchers investigated the treatment patterns for adults in the United States with alopecia areata from 2015 to 2020.
